Informations techniques
Exploitant
IDORSIA PHARMACEUTICALS FRANCE SAS
Présentation
QUVIVIQ 25 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 0 2)
QUVIVIQ 50 mg, comprimé pelliculé
plaquette(s) PVC PVDC PVC-Aluminium de 30 comprimé(s) (CIP : 34009 302 504 2 6)
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
Dxqdmg8F0MLkfeMX